The regional director for clinical trials for the Kaiser Permanente Department of Research and Evaluation in Southern California discusses how for some parents the convenience of fewer doses or whether the vaccines can be given with other immunizations may be deciding factors.
William Towner, MD, has been involved in research on infectious diseases since 2000 and served as a principal investigator for 150 clinical trials at Kaiser Permanente Southern California.
Students from the Kaiser Permanente Bernard J. Tyson School of Medicine apply new clinical skills to help protect community from COVID-19.
Collaboration between Kaiser Permanente’s care delivery system and research programs has driven the successful implementation of remdesivir clinical trials across regions.
Kaiser Permanente’s clinical trials help advance treatment for health conditions and diseases ranging from heart disease and cancer to AIDS and COVID-19.